Thermal and Rheological Properties of Physical Gels Formed from Benzylidene- D-sorbitol Derivatives

DOI: 10.1246/bcsj.71.1457

Source and publish data:

Bulletin of the Chemical Society of Japan p. 1457 - 1466 (1998)

Update date:2022-08-03

Topics:

Authors:

Watase, Mineo

Itagaki, Hideyuki

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1246/bcsj.71.1457

The thermal and Theological properties of gels formed from 2,4-(mono)-O-benzylidene-D-sorbitol (MBS), 1,3 : 2,4-di-O-benzylidene-D-sorbitol (DBS), and 1,3 : 2,4 : 5,6-tri-O-benzylidene-D-sorbitol (TBS) in ethylene glycol (EG) and from DBS in glycerol (GL)

Full text of DOI:10.1246/bcsj.71.1457

Products guided by the article

Product name:1,3:2,4:5,6-tri-O-benzylidene-D-sorbitol

Cas No:61473-61-8

R&D Labs maybe for 61473-61-8

Jinan Finer Chemical Co., Ltd

website:http://www.finerchem.com

Contact:+86-531-88989536

Address:New Material Industry Park, Jinan Ciyt, China
Sichuan Highlight Fine Chemicals Co., Ltd.

Contact:+86-28-8525 1605

Address:A5-102 Airport base,388 West Airport Huang He Zhong Lu,2 Section
GIHI CHEMICALS CO.,LIMITED

Contact:+86-571-86217390

Address:No.567 Dengcai Street,Sandun,Westlake District,Hangzhou310030,Zhejiang,China.
Shantou Baokang Pharmaceutical Co., Ltd.

Contact:+86-754-88873487

Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
BIOS CHEMICALS

Contact:+33-5-34012600

Address:28 ZA des Pignès

Relevant to this article

Synthesis and antimicrobial activity of novel 3-benzyloxy-4-substituted-2- azetidinones: Formation of a hydrophobic layer via a self-organization effect

Doi:10.1080/10426507.2011.553208
(2011)
Reaction of N (butoxymethyl)dialkylamines and N,N' methylenebis(dialkylamine)s with N (1 cyclohexen 1 yl)dialkylamines

Doi:10.1248/cpb.24.2494
(1976)
Doi:10.1021/jo00430a012
(1977)
A study of the ring-opening of lactides and related cyclic esters by Ph₂SnX₂ and Ph₃SnX compounds (X = NMe ₂, OR)

Doi:10.1039/b300101f
(2003)
Doi:10.1021/jo01024a046
(1964)
Discovery of an orally efficacious inhibitor of coagulation factor Xa which incorporates a neutral P₁ ligand

Doi:10.1021/jm020384z
(2003)

Article Doi